Navigation
-
Advaxis to Present at 2017 BIO International Convention
-
Advaxis to Be Featured on Worldwide Business with kathy ireland®
-
Advaxis Details Registrational Trials, EU Regulatory and Commercial Plans at Annual Investor & Analyst Day
-
Advaxis to Webcast Investor & Analyst Day 2017
-
Update: Webcast of Advaxis Presentation at Jefferies 2017 Global Healthcare Conference Now Available
-
Advaxis to Present at Jefferies 2017 Global Healthcare Conference
-
Advaxis and Bristol-Myers Squibb Announce Clinical Collaboration to Evaluate ADXS-DUAL and Opdivo (nivolumab) in Metastatic Cervical Cancer
-
Advaxis to Host Investor & Analyst Day on June 12
-
Advaxis Provides Phase 1 Data of Higher Dose Axalimogene Filolisbac
-
Erin Andrews to Participate in Cervical Cancer Educational Forum Hosted by Sylvester Comprehensive Cancer Center and Gilda’s Club, Sponsored by Advaxis
